Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 10/31/16 → 7/12/21 |
Funding
- Covance: $56,228.00
A Multicenter, Randomized, Double Blind, Placebo-Controlled Phase III study to Evaluate the Efficacy and Safety of Elafibranor in Patients with Nonalcoholic Steatohepatitis (NASH) and Fibrosis
- Grigorian, Alla (PI)
- Leyson, Christina (CoI)